Nicolas Cage, Diane Kruger and Justin Bartha raced from conspiracy theory to conspiracy theory in this 2004 blockbuster about stealing the Declaration of Independence.
What is essential reading? Texas has an answer: Classics, including the Bible.
At a conference on reconstruction, the focus shifted to private investment, not donor assistance.
Some people have fought Ebola containment measures in the Democratic Republic of Congo. Scholars have seen similar responses across societies and throughout history.
Mr. Lasher, the likely successor to Representative Jerry Nadler, has an unusual back story: As a teenager, he was a prodigy who performed magic tricks on national television.
Troy Jackson’s emergence as the clear front-runner to replace Graham Platner spares the party some challenges but points to some new ones.
Some Republicans fear the party is poised to repeat past mistakes by nominating candidates in Tuesday’s primaries who are viewed as too extreme to sway moderate voters.
Chinese companies are offering artificial intelligence that is nearly as good as the leading U.S. technologies, but it’s still America’s race to lose.
The Trump administration is showing signs it could ban cutting-edge Chinese AI models — a momentous move that could lock in dominance by OpenAI and Anthropic. Why it matters: Parts of the administration have tried to implement de facto bans on foreign open-source models before, knowledgeable sources tell Axios. Last week's rise of Chinese model Kimi is reigniting those efforts. Pro-competition voices fear the implications. - U.S. companies are increasingly using open-source models from China because they're cheaper and, as seen by the advent of Kimi , just about as good as the domestic technology. Behind the scenes: The Commerce Department last year considered adding multiple Chinese AI labs to its "Entity List," which would…
The Trump administration is showing signs it could ban cutting-edge Chinese AI models — a momentous move that could lock in dominance by OpenAI and Anthropic. Why it matters: Parts of the administration have tried to implement de facto bans on foreign open-source models before, knowledgeable sources tell Axios. Last week's rise of Chinese model Kimi is reigniting those efforts. Pro-competition voices fear the implications. - U.S. companies are increasingly using open-source models from China because they're cheaper and, as seen by the advent of Kimi , just about as good as the domestic technology. Behind the scenes: The Commerce Department last year considered adding multiple Chinese AI labs to its "Entity List," which would…Open
Artificial intelligence is dramatically speeding up drug development — and a proprietary survey shows how it's priming a bigger automation push that's changing the trajectory of early stage pharma research. Why it matters: The TD Cowen survey of 80 biopharma leaders and insiders finds AI is compressing drug developers' preclinical costs and timelines by as much as 70%. - That's fueling demand for cutting-edge software, sequencing tools and computer models that will help churn out more experimental treatments in the next five years. The big picture: AI can't replace scientific intuition. But the way it can streamline the grueling R&D before human testing begins is making computer screens as important a feature of drug design as…
Artificial intelligence is dramatically speeding up drug development — and a proprietary survey shows how it's priming a bigger automation push that's changing the trajectory of early stage pharma research. Why it matters: The TD Cowen survey of 80 biopharma leaders and insiders finds AI is compressing drug developers' preclinical costs and timelines by as much as 70%. - That's fueling demand for cutting-edge software, sequencing tools and computer models that will help churn out more experimental treatments in the next five years. The big picture: AI can't replace scientific intuition. But the way it can streamline the grueling R&D before human testing begins is making computer screens as important a feature of drug design as…Open